Retinoic Acid Sensitizes Melanoma Cells to Taxol
Author Information
Author(s): Huang Ying, Minigh Jennifer, Miles Sarah, Niles Richard M
Primary Institution: Department of Biochemistry and Microbiology, Joan C. Edwards School of Medicine, Marshall University
Hypothesis
Does retinoic acid treatment sensitize melanoma cells to taxol-mediated growth inhibition by decreasing ATF-2 phosphorylation?
Conclusion
Retinoic acid treatment decreases ATF-2 phosphorylation and significantly increases the sensitivity of melanoma cells to taxol.
Supporting Evidence
- Retinoic acid treatment reduced ATF-2 phosphorylation by up to 75%.
- Without retinoic acid, the taxol IC50 was approximately 50 nM.
- With retinoic acid pretreatment, the taxol IC50 decreased to 1 nM.
Takeaway
This study found that a substance called retinoic acid can help make melanoma cells more sensitive to a cancer drug called taxol by changing how a protein called ATF-2 works.
Methodology
B16 mouse melanoma cells were treated with retinoic acid and then exposed to taxol to measure changes in cell growth and ATF-2 phosphorylation.
Limitations
The study primarily focuses on a single melanoma cell line, which may not represent all melanoma types.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website